Steven Cohen’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-14,700
Closed -$497K – 3946
2026
Q1
$497K Buy
+14,700
New +$417K ﹤0.01% 3116

Other funds holding AGIO

Steven Cohen's AGIO Position: Q3 2026 in Review

Steven Cohen sold out of Agios Pharmaceuticals (AGIO) in Q3 2026, closing a stake of 506,344 shares — an estimated $18.8M sold.

Steven Cohen first reported a position in AGIO in Q2 2014 and held it in 20 quarters. The position peaked at $33.2M in Q1 2018. 243 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Steven Cohen reported no remaining Agios Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 506,344 Agios Pharmaceuticals shares in Q3 2026, an estimated $18.8M.
  • Steven Cohen first reported a position in Agios Pharmaceuticals in Q2 2014 and held it in 20 quarters.
  • Steven Cohen's Agios Pharmaceuticals position peaked at $33.2M in Q1 2018.
  • 243 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.